Harvey Norman Holdings

Size: px
Start display at page:

Download "Harvey Norman Holdings"

Transcription

1 Equities Australia Retailing 3 May 2012 Hold Important: The above recommendation has been made on a 12 month view and may not suit your investment needs or timeframe. The basis it is prepared on is summarised on the last page of this report. PLEASE CONTACT YOUR ADVISER TO DISCUSS THIS GENERAL RECOMMENDATION BEFORE ACTING ON IT. Moderate Volatility Harvey Norman Holdings Harvey Normalise? The commentary around today's result supported our view that current levels of acute discounting should abate. HVN's focus on cash flow expansion in 3Q12, together with industry stock liquidation, should not be repeated to the same extent, we believe. Our concern for HVN, however, is that sales momentum has not improved in line with other retailers, suggesting to us market share losses in AV and IT. TP A$1.82 (from A$2.00) Event: 3Q12 trading a significant step down HVN RBS Refiner Price (close 02 May) A$2.07 3M high/low A$2.22/1.85 Market cap A$2.21bn Av (12M) turnover A$7.90m Freefloat 45% Reuters HVN.AX Bloomberg HVN AU Net debt (cash) FY11 A$488.98m 3yr EPS CAGR 12-14F (5.4)% Income (2013F div yield) 4.3% Source: RBS forecasts, Bloomberg RBS vs consensus NPAT ($Am) RBS Cons % diff 20121F % 2013F % 2014F % Source: RBS, IBES HVN today reported its 3Q12 unaudited results, with PBT down 44% on the pcp. If the same momentum is carried through 4Q12, by our calculation the 2H12 franchisee EBIT margin would decline approximately 300bp to 1.7%. However, there is evidence from today s analyst briefing to support our view that current levels of discounting are acute and short term. Evidence includes: 1) Harvey Norman management had a dedicated plan in 3Q12 to accelerate franchisee cashflow (stock liquidation); 2) the company cleared A$35m of precautionary IT stock purchased in anticipation of stock shortages with the Thailand floods; and 3) liquidation of A$40m of WOW Sight & Sound inventory. In other regions, Ireland revenue continues to improve off a low base, translating into a lower constant currency PBT loss. NZ revenues and margin remain challenged, although have held up better than Australian franchisees. Forecasts: Downgrades to FY12 and FY13 We lower our NPAT forecasts by 11% to A$191m in FY12 and 20% to A$179m in FY13. Our forecasts reflect management s views that Australian franchisee turnover will continue to contract in FY13. We do, however, factor in margin improvement in 2H13 as the current pricing environment is cycled. In a scenario whereby Dick Smith is retained by Woolworths (downscaled or closed), it would likely bring more protracted margin pressure and therefore downside risk to our revised FY13 forecasts. As irrational discounting eases and with pending new product releases in the TV category specifically, earnings momentum should recover. Further interest rate cuts would also be beneficial. Valuation: Hold recommendation maintained; TP cut to A$1.82 Price performance (1M) (3M) (12M) Price (A$) Absolute (%) Rel to mkt*(%) *S&P/ASX200 Source: Bloomberg Key events Date Aug-12 Oct-12 RBS Morgans Limited (A.B.N ) AFSL A Participant of ASX Group Sourced from RBS Equities (Australia) Limited, ABN , AFS Licence Event FY result AGM Source: Company We believe HVN has a strong investment case; however investors risk downside earnings surprises in FY13F. Property assets continue to underpin the valuation, with the lack of smallscale developer activity creating further opportunities for HVN. Sector consolidation is a mediumterm opportunity across most segments. Given the near-term risk to earnings, however, we rate the stock Hold. We lower our target price and valuation to A$1.82 (from A$2.00) to reflect the downgrades to our earnings forecasts. Key downside risks to our target price are an extended downturn in retail activity, new competitors opening a larger number of stores than expected and potentially taking share from Harvey Norman, and sustained softness in Ireland earnings. The key upside risk is a greater-than-expected improvement in underlying retail conditions. Key forecasts year to Jun FY10A FY11A FY12F FY13F FY14F EBITDA (A$m) & & & Normalised net profit (A$m)¹ & & & Norm fully diluted EPS (c)¹ & & & Normalised EPS growth Dividend per share (c) & 9.00 & & Dividend yield (%) Normalised PE Use of %& indicates that the line item has changed by at least 5%. 1. Pre non-recurring items and post preference dividends Accounting standard: A-IFRS Important disclosures regarding companies that are the subject of this report and an explanation of recommendations and volatility can be found at the end of this document.

2 RBS Equities Forecasts: Harvey Norman Holdings Income statement A$m, year to June FY10A FY11A FY12F FY13F FY14F Revenue Cost of sales n/a n/a n/a n/a n/a Gross profit Operating costs EBITDA DDA & Impairment (ex gw) EBITA Goodwill (amort/impaired) n/a n/a n/a n/a n/a EBIT Net interest Associates (pre-tax) n/a n/a n/a n/a n/a Other pre-tax items Reported PTP Taxation Minority interests Other post-tax items Reported net profit Tot normalised items Normalised EBITDA Normalised EBIT Normalised PTP Normalised net profit Balance sheet A$m, year ended June FY10A FY11A FY12F FY13F FY14F Cash & market secs (1) Other current assets Tangible fixed assets Intang assets (incl gw) Oth non-curr assets Total assets Short term debt (2) Trade & oth current liab Long term debt (3) Oth non-current liab Total liabilities Total equity (incl min) Total liab & sh equity Net debt Cash flow statement A$m, year to June FY10A FY11A FY12F FY13F FY14F EBITDA Change in working capital Net interest (pd) / rec Taxes paid Other oper cash items Cash flow from ops (1) Capex (2) Disposals/(acquisitions) Other investing cash flow Cash flow from invest (3) Incr / (decr) in equity Incr / (decr) in debt Ordinary dividend paid Preferred dividends (4) n/a n/a n/a n/a n/a Other financing cash flow Cash flow from fin (5) Forex & disc ops (6) Inc/(decr) cash ( ) Equity FCF (1+2+4) Page 2

3 Key takeaways FY13 forecasts Below we detail our revised forecasts for FY12 and FY13. Management commented in today s analyst call that it is purchasing FY13 stock in anticipation that demand will be lower than in FY12. Our revenue forecasts for Australian franchisees reflect this. We expect the franchisee margins to deteriorate in 1H13 but recover in 2H13 as intensive tactical discounting is cycled. Table 1 : JBH: FY12 and FY13 forecasts A$m 1H12 1H13 Chg % 2H12 2H13 Chg % FY12 FY13 Chg % Franchising Sales % % % Franchising EBIT % % % Margin % 4.1% 3.2% -94bp 1.7% 2.3% 55bp 3.0% 2.7% -25bp Property EBIT % % % New Zealand Sales % % % New Zealand EBIT % % % Margin % 7.1% 7.2% 5bp 7.0% 8.7% 170bp 7.1% 7.9% 84bp Ireland Sales % % % Ireland EBIT % % % Other EBIT % % % Total EBIT % % % Source: RBS forecasts More a corporate model than a franchise model A number of questions in the analyst conference call focused on the potential fragility of AV/IT franchisees as competition accelerates. Management emphasised again today its intention to use the franchisors balance sheet to support franchisees through their working capital requirements. As such, we maintain the view that HVN maintains tight controls on franchisees to the extent that the model is effectively corporatized. The Australian store operational structure is becoming increasingly similar to the corporate model used in NZ. 3Q12 likely to be a low point for the franchisee margin In our view, there is enough evidence from today s analyst briefing to determine that current levels of discounting are acute and short term. Evidence includes: 1) Harvey Norman management had a dedicated plan to accelerate franchisee cashflow (stock liquidation); 2) Harvey Norman has successfully cleared A$35m of precautionary stock purchased at the time of the Thailand floods; and 3) the WOW sight & Sound liquidation. In other regions, Ireland revenue continues to improve off a low base, translating to a lower constant currency PBT loss. Risk of more store closures The Ex-Clive Peeters and Ex-Rick Hart stores have delivered improved operational results after having been rebadged as Harvey Norman. However, the improvement seems to be low and we estimate unlikely to be more than the marketing and head office costs saved by closing the CPR business. In our view, cannibalisation continues to be a major issue. Below, we show the Clive Peeters and Rick Hart stores converted to Harvey Norman and the number of existing Harvey Norman stores already in the same suburb and within a 5km radius. More than 50% of converted stores have an existing store in the same suburb. As such, we would expect further store closures in future years. Page 3

4 Table 2 : Store overlap with existing HVN network Store Same suburb Less than 5km Store Same suburb Less than 5km Braybrook 1 1 Loganholme 1 Coburg 1 Macgregor 1 Moorabbin 1 Mackay 1 Mornington Maroochydore Richmond 1 Morayfield 1 Ringwood 1 Belmont 1 Moonah 1 Joondalup 1 Aspley 1 Midland 1 Burleigh Waters Victoria Park 1 Source: Company data, RBS Earnings forecast changes We make downward revisions to our forecasts, as per the table below. Table 3 : RBS earnings changes FY12F FY13F FY14F (A$m) Previous Revised % change Previous Revised % change Previous Revised % change EBIT % % % NPAT % % % Normalised EPS (c) % % % Reported EPS (c) % % % DPS (c) % % % Source: RBS forecasts Investment view We believe HVN has a strong investment case; however investors risk downside earnings surprises near term. Property assets continue to underpin the valuation, with the lack of smallscale developer activity creating further opportunities for HVN. Sector consolidation remains a medium-term opportunity across most segments. Given the near-term risk to earnings, however, we rate the stock Hold. We lower our target price and valuation to A$1.82 (from A$2.00), reflecting the downgrades to earnings. Our PE and EV/EBIT target multiples are set at a discount to IBES Core Industrial multiples to reflect structural issues in the sector and the potential for downside to HVN earnings. Table 4 : HVN valuation summary Valuation measure Core Industrials multiples (FY13) Target multiple Target price PE $1.52 EV/EBIT $1.55 DCF $2.40 Average $1.82 Source: IBES, RBS estimates Page 4

5 Table 5 : Harvey Norman 3Q12 sales summary System sales (Harvey Norman complexes, commercial divisions and other outlets in Australia, New Zealand, Slovenia and Ireland) 1Q12 2Q11 3Q12 YTD Percentage growth -3.8% -8.2% -8.1% -6.7% Like-for-like growth -3.8% -8.0% -7.5% -6.6% Category performance Electrical Price deflation, WOW Sight & Sound inventory clearance (A$40m) and Dick Smith store closures all impacted GP margin and sales during the quarter. Furthermore, a proportion of A$200m in franchisee account receivables were recovered as franchisee inventory was cleared during the quarter. Computers HVN cleared additional stock (A$35m) as a result of stockpiling in anticipation of supply constraints with Thailand floods. Furniture & Bedding Category has continued to grow revenue during the quarter despite an industry slowdown in the property sector. Australian franchise operation 3Q12 Growth (constant currency) Like-for-like growth (constant currency) -9.2% -7.7% Key takeaways Appliance and white goods performed solidly, with growth in the 3Q, furniture and bedding sales (and GP margins) were steady. AV and computers remained challenging categories. Tactical and clearance discounting should abate in 2H13F Windows 8 release expected in 4Q13, which should help drive some upgrades for Computers. Purchases for FY13 are expected by management to be slightly down yoy, in line with 3Q trading. New Zealand 3Q12 Growth (constant currency) Like-for-like growth (constant currency) -6.6% -7.9% Key takeaways Ongoing weak consumer sentiment has led to the continuation of soft sales in 3Q12 Sales & GP margin remain under pressure, but not to the extent experienced in Australia. A weaker currency is preventing comparatively higher levels of price deflation. Ireland 3Q12 Growth (constant currency) Like-for-like growth (constant currency) 1.3% 1.3% Key takeaways Like-for-like growth (constant currency) of 1.3% for 3Q12 indicates that reported like-for-like growth was flat due to the 5.9% deflation of the EUR/AUD over the pcp. In constant currency terms, the 2H loss should reduce on pcp. This would further reduce reflecting currency translation. Improved momentum in sales, however political issues (particularly French election) may cast general doubt over EU recovery near term. Slovenia 3Q12 Growth (constant currency) Like-for-like growth (constant currency) 9.3% 1.3% Key takeaways Like-for-like growth of -1.3% (constant currency) was affected by the depreciated EUR. New space to drive continued sales growth Company Overview Harvey Norman Holdings (HVN) is a retail company specialising in homewares, furniture, bedding, carpet and flooring, lighting, kitchens and bathrooms, and electrical goods. It operates through Harvey Norman franchises in Australia and company-owned stores in New Zealand. The company also has retail operations in Singapore, Malaysia, Slovenia and Ireland. HVN has a substantial property investment portfolio, including premises leased to HVN franchisees and other third parties. Page 5

6 HVN financial summary Year to 30 Jun (A$m) AIFRS AIFRS AIFRS AIFRS AIFRS Closing price (A$) 2.07 Price target (A$) 1.82 Income statement 2010A 2011A 2012F 2013F 2014F Valuation metrics Divisional sales Preferred methodology Blended valuation Val'n (A$) $ 1.82 Total revenue DCF valuation inputs EBITDA Rf 5.25% 10-year rate 5.25% Depreciation Rm-Rf 6.00% Margin 0.7% EBIT Beta 0.73 Kd 6.00% Net interest expense CAPM (Rf+Beta(Rm-Rf)) 9.6% Ke 9.6% Pre-tax profit E/EV*Ke+D/EV*Kd(1-t) NPV cash flow (A$m) Income tax expense Equity (E/EV) 90.0% Minority interest (A$m) 32.6 After-tax profit Debt (D/EV) 10.0% Net debt (A$m) Minority interests Interest rate 6.00% Investments (A$m) NPAT Tax rate (t) 30.0% Equity market value (A$m) Significant items WACC 9.1% Diluted no. of shares (m) NPAT post abnormals DCF valuation (A$) 2.40 Divisional sales revenue 2010A 2011A 2012F 2013F 2014F Multiples 2011A 2012F 2013F 2014F Franchising Operations Enterprise value (A$m) Property Investments EV/Sales (x) New Zealand EV/EBITDA (x) Asia EV/EBIT (x) Non-Franchised Retail PE (pre-goodwill) (x) Financial Services PEG (pre-goodwill) (x) Slovenia Corporate (Other) At target price 2011A 2012F 2013F 2014F Ireland EV/EBITDA (x) Other Property PE (pre-goodwill) (x) Divisional EBIT 2010A 2011A 2012F 2013F 2014F Comparable company data (x) 2012F 2013F 2014F Franchising Operations Woolworths EV/EBITDA Property Investments Year to 30 Jun EV/EBIT New Zealand PE Asia PEG Non-Franchised Retail JB Hi-Fi EV/EBITDA Financial Services Year to 30 Jun EV/EBIT Slovenia PE Corporate (Other) PEG Ireland Other Property Per share data 2011A 2012F 2013F 2014F Cash flow statement 2010A 2011A 2012F 2013F 2014F No. shares EBITDA EPS (cps) Change in working capital EPS (normalised) (c) Net interest (pd)/rec Dividend per share (c) Taxes paid Dividend payout ratio (%) Other oper cash items Dividend yield (%) Cash flow from ops (1) Capex (2) Growth ratios 2011A 2012F 2013F 2014F Disposals/(acquisitions) Sales growth 10.4% -6.5% -0.5% 5.3% Other investing cash flow Operating cost growth 16.0% -3.5% -1.1% 4.3% Cash flow from invest (3) EBITDA growth -8.3% -19.8% 2.8% 10.4% Incr/(decr) in debt EBITA growth -11.7% -24.1% -1.0% 13.7% Ordinary dividend paid Divisional EBIT growth Other financing cash flow Franchising Operations -15.6% -47.9% -7.1% 13.2% Cash flow from fin (4) Property Investments 22.6% 11.9% 3.3% 0.7% Inc/(decr) cash (1+3+4) New Zealand -12.8% -9.1% 15.2% 6.4% Equity FCF (1+2) Asia 32.0% -22.3% 16.1% 11.8% Non-Franchised Retail % % % 9.0% Balance sheet 2010A 2011A 2012F 2013F 2014F Financial Services 40.9% -40.5% % n.m. Cash & deposits Slovenia 49.4% -70.1% 59.7% 50.9% Trade debtors EBIT growth -11.7% -24.1% -1.0% 13.7% Inventory NPAT growth -12.6% -21.1% -6.4% 14.5% Investments Pre-goodwill NPAT growth -16.6% -21.1% -6.4% 14.5% Goodwill Pre-goodwill EPS growth -16.6% -21.1% -6.4% 14.5% Other intangible assets Normalised EPS growth -16.6% -21.1% -6.4% 14.5% Fixed assets Other assets Operating performance 2011A 2012F 2013F 2014F Total assets Asset turnover (%) Short-term borrowings EBITDA margin (%) Trade payables EBIT margin (%) Long-term borrowings Net profit margin (%) Provisions Return on net assets (%) Other liabilities Net debt (A$m) Total liabilities Net debt/equity (%) Preference shares Net interest/ebit cover (x) Share capital ROIC (%) Retained earnings Other equity Internal liquidity 2011A 2012F 2013F 2014F Total equity Current ratio (x) Minority interest Receivables turnover (x) Total shareholders' equity Payables turnover (x) Page 6

7 QUEENSLAND PARRAMATTA (02) BRISBANE (07) PORT MACQUARIE (02) BUNDABERG (07) SCONE (02) CAIRNS (07) SYDNEY LEVEL 9 (02) CALOUNDRA (07) SYDNEY LEVEL 33 (02) CAPALABA (07) SYDNEY MACQUARIE STREET (02) CHERMSIDE (07) SYDNEY REYNOLDS EQUITIES (02) EDWARD STREET (07) WOLLONGONG (02) EMERALD (07) GLADSTONE (07) ACT GOLD COAST (07) CANBERRA (02) IPSWICH (07) MACKAY (07) VICTORIA MILTON (07) MELBOURNE (03) NOOSA (07) BERWICK (03) REDCLIFFE (07) BRIGHTON (03) ROCKHAMPTON (07) CAMBERWELL (03) SPRING HILL (07) CARLTON (03) SUNSHINE COAST (07) FARRER HOUSE (03) TOOWOOMBA (07) GEELONG (03) TOWNSVILLE (07) RICHMOND (03) YEPPOON (07) SOUTH YARRA (03) TRARALGON (03) NEW SOUTH WALES WARRNAMBOOL (03) SYDNEY (02) ARMIDALE (02) WESTERN AUSTRALIA BALLINA (02) PERTH (08) BALMAIN (02) CHATSWOOD (02) SOUTH AUSTRALIA COFFS HARBOUR (02) ADELAIDE (08) GOSFORD (02) NORWOOD (08) HURSTVILLE (02) MERIMBULA (02) NORTHERN TERRITORY NEUTRAL BAY (02) DARWIN (08) NEWCASTLE (02) NEWPORT (02) TASMANIA ORANGE (02) HOBART (03) DISCLAIMER - RBS MORGANS LIMITED The information contained in this report is general advice only, and is made without consideration of an individual s relevant personal circumstances. RBS Morgans Limited ABN , its related bodies corporate, directors and officers, employees, authorised representatives and agents ( RBS Morgans ) do not accept any liability for the results of any actions taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their RBS Morgans investment adviser before doing so. Those acting upon such information without advice do so entirely at their own risk. This report was prepared as private communication to clients and is not intended for public circulation, publication or for use by any third party. The contents of this report may not be reproduced in whole or in part without the prior written consent of RBS Morgans. While this report is based on information from sources which RBS Morgans believes are reliable, its accuracy and completeness cannot be guaranteed. Any opinions expressed reflect RBS Morgans judgement at this date and are subject to change. RBS Morgans is under no obligation to provide revised assessments in the event of changed circumstances. This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or commitment whatsoever. DISCLOSURE OF INTEREST RBS Morgans may from time to time hold an interest in any security referred to in this report and may, as principal or agent, sell such interests. RBS Morgans may previously have acted as manager or co-manager of a public offering of any such securities. RBS Morgans' affiliates may provide or have provided banking services or corporate finance to the companies referred to in the report. The knowledge of affiliates concerning such services may not be reflected in this report. RBS Morgans advise that it may earn brokerage, commissions, fees or other benefits and advantages, direct or indirect, in connection with the making of a recommendation or a dealing by a client in these securities. Some or all of our Authorised Representatives may be remunerated wholly or partly by way of commission. RECOMMENDATION STRUCTURE For a full explanation of the recommendation structure, refer to our website at If you no longer wish to receive RBS Morgans publications please advise your local RBS Morgans office or write to RBS Morgans Limited, Reply Paid 202, Brisbane QLD 4001 and include your account details. Page 7

Exchange traded Government Bonds

Exchange traded Government Bonds Morgans Analyst James LAWRENCE T (61) 7 3334 4547 E james.lawrence@morgans.com.au Exchange traded Government Bonds In an exciting development for investors, they will now be able to access exchange traded

More information

Financial Services Guide

Financial Services Guide Financial Services Guide A guide to our relationship with you and others Version 5 February 2014 Morgans and CIMB Please visit www.morgans.com.au to understand the products and services within our alliance.

More information

ebetet COMPANY NOTE period. We estimate that CARDIT EBITDA will grow by 17% yoy in FY15.

ebetet COMPANY NOTE period. We estimate that CARDIT EBITDA will grow by 17% yoy in FY15. Gaming Australia ebetet EBT AU / EBT.AX Current A$4.00 Market Cap Avg Daily Turnover Free Float Target A$4.57 US$60.43m US$0.11m 70.0% Prev. Target A$ A$70.48m A$0.12m 17.40 m shares Up/Downside 14.3%

More information

K2 Asset Management. A performance driven model

K2 Asset Management. A performance driven model Vol m Financial Services - Others Australia Equity research December 22, 20 HOLD Current price: Target price: A$0.70 A$0.71 Previous target: A$ Up/downside: 2.2% Reuters: Bloomberg: Market cap: Average

More information

Fortescue Metals Group

Fortescue Metals Group Vol m Mining Australia Equity research October 30, 2015 HOLD (no change) Current price: Target price: Previous target: A$2.20 A$2.16 A$2.16 Up/downside: -1.8% Reuters: Bloomberg: Market cap: Average daily

More information

1300 Smiles. Smiles all round

1300 Smiles. Smiles all round ADD Current price: Target price: A$7.11 A$7.94 Previous target: A$ Up/downside: 11.7% Reuters: Bloomberg: Market cap: Average daily turnover: ONT.AX ONT AU US$122.0m A$168.4m US$0.03m A$0.05m Current shares

More information

TPG Telecom. Changing our tune

TPG Telecom. Changing our tune Vol m Telco - Integrated Australia Equity research December 6, 2017 HOLD (previously REDUCE) Current price: Target price: Previous target: A$6.11 A$5.95 A$4.30 Up/downside: -2.6% Reuters: Bloomberg: Market

More information

Fairfax Media. Equity Australia Media. Outlook will improve, but not just yet. Buy. 21 August 2008

Fairfax Media. Equity Australia Media. Outlook will improve, but not just yet. Buy. 21 August 2008 Equity Australia Media 21 August 2008 Change of target price Buy Target price A$3.33 (from A$3.68) Price A$2.82 Short term (0-60 days) n/a Price performance (1M) (3M) (12M) Price (A$) 3.01 3.47 4.73 Absolute

More information

Presentation of Results for Half-Year Ended 31 December 2011

Presentation of Results for Half-Year Ended 31 December 2011 Presentation of Results for Half-Year Ended 31 December 2011 Harvey Norman Holdings Limited ABN 54 003 237 545 Agenda 1. Strategic Overview 2. Franchisee Sales Revenue 3. Franchisee Trading Performance

More information

Company Review 1300SMILES. Corporate Activity Dental Partners. ONT A$6.72 (TP $6.26) Recommendation Hold (no change) Risk Assessment Medium

Company Review 1300SMILES. Corporate Activity Dental Partners. ONT A$6.72 (TP $6.26) Recommendation Hold (no change) Risk Assessment Medium Ord Minnett Research 2 October 2013 1300SMILES Corporate Activity Dental Partners Event: A consortium led by private equity firm, Archer Capital has recently made an indicative offer for 100% of New Zealand

More information

Cash Converters Intl.

Cash Converters Intl. MICROCAP COMPANY RESEARCH Cash Converters Intl. 22 nd November 2012 GICS: Diversified Financials Consumer Finance 1Q13 Trading Update RECENT NEW S Cash Converters [ASX:CCV] recently provided a trading

More information

Mesoblast. Completes equity raising

Mesoblast. Completes equity raising Equity Australia Pharma & Biotech 30 March 2009 Buy Target price A$1.40 (from A$1.45) Price A$0.80 Short term (0-60 days) n/a Price performance (1M) (3M) (12M) Price (A$) 0.80 0.90 0.61 Absolute (%) 0.0-11.1

More information

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts Date Theme Company Update Company MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction We moderate to HOLD (from Buy) with a revised target of $2.36 p/share. We were previously encouraged

More information

Self Managed Super Fund Administration

Self Managed Super Fund Administration Self Managed Super Fund Administration How can Morgans make a difference to you? Our clients have been accessing a wealth of experience in financial services since 1987. While our reputation was established

More information

Praemium (PPS) COMPANY REPORT. Quartermaster

Praemium (PPS) COMPANY REPORT. Quartermaster 10 October 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.45 SNAPSHOT Monthly Turnover $9.2mn Market Cap $162mn Shares Issued 399.6mn 52-Week High $0.54 52-Week

More information

Platinum Asset Management

Platinum Asset Management AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium

More information

Vimy Resources. Mulga Rock Australia s next uranium mine? ADD (no change)

Vimy Resources. Mulga Rock Australia s next uranium mine? ADD (no change) Vol th Mining Australia Equity research April 18, 2016 ADD (no change) Current price: Target price: Previous target: A$0.31 A$0.47 A$0.51 Up/downside: 54.2% Reuters: Bloomberg: Market cap: Average daily

More information

Upside wrapped in red tape

Upside wrapped in red tape Equities Australia Energy 25 September 2012 Company Spotlight EEG120925 Empire Energy Group Upside wrapped in red tape RBS Morgans Refiner Price (close 10-Sep) A$0.18 3M high/low A$0.21 / 0.13 Market cap

More information

Consolidated Operations Group (COG)

Consolidated Operations Group (COG) Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation

More information

Zip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher.

Zip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher. Delivering against expectations Z1P s Mar-18 qtrly report delivered well against our expectations. Positive operating cash flow for the qtr of $1.6m was a +$2.8m improvement qoq, despite the receivables

More information

Company Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High

Company Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High Company Review Ord Minnett Research Friday, June 24, 2011 Centaurus Metals Jambreiro Resource upgrade Centaurus has upgraded the JORC resource at its flagship, Jambreiro Iron Ore Project in Brazil. The

More information

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index

More information

Regional Express. Equity Australia Transportation. Buy me. Buy

Regional Express. Equity Australia Transportation. Buy me. Buy Equity Australia Transportation 31 August 2011 Buy Target price A$1.26 (from A$1.25) Price A$0.965 Short term (0-60 days) n/a Price performance (1M) (3M) (12M) Price (A$) 0.89 0.95 1.19 Absolute (%) 8.4

More information

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates 11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST

More information

Praemium (PPS) COMPANY REPORT. Model performance

Praemium (PPS) COMPANY REPORT. Model performance 14 August 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.41 SNAPSHOT Monthly Turnover $9.5mn Market Cap $165mn Shares Issued 398.5mn 52-Week High $0.54 52-Week

More information

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016. AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium

More information

Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Produced by: ABN AMRO Equities Australia Ltd Wednesday 29 August 2007 Reaching for the prize In FY07, CUV posted NPAT in line with our forecast. In FY08, CUV hopes to further progress its lead compound,

More information

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins. AUSTRALIA SGF AU Price (at 07:57, 27 Oct 2016 GMT) Outperform A$3.85 Valuation - PER A$ 3.92-4.18 12-month target A$ 4.37 12-month TSR % +18.1 Volatility Index Medium GICS sector Commercial & Professional

More information

SG Fleet Group. Another UK acquisition. Earnings and target price revision

SG Fleet Group. Another UK acquisition. Earnings and target price revision AUSTRALIA SGF AU Price (at 08:26, 30 Nov 2016 GMT) Outperform A$3.23 Valuation - PER A$ 3.96-4.22 12-month target A$ 4.37 12-month TSR % +41.0 Volatility Index High GICS sector Commercial & Professional

More information

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA CDD AU Price (at 04:53, 17 Feb 2015 GMT) Neutral A$2.88 Valuation - Sum of Parts A$ 2.80-3.43 12-month target A$ 3.12 12-month TSR % +18.4 Volatility Index Medium GICS sector Capital Goods Market

More information

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA AUSTRALIA SXL AU Price (at 05:10, 27 Mar 2017 GMT) Neutral A$1.37 Valuation A$ - DCF (WACC 8.0%, beta 1.2, ERP 5.0%, RFR 3.3%) 1.39 12-month target A$ 1.30 12-month TSR % +0.8 Volatility Index Medium GICS

More information

Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Equity Australia Pharmaceuticals & Biotechnology 29 August 2008 Change of target price Buy Target price A$1.00 (from A$0.95) Price A$0.300 Short term (0-60 days) n/a Price performance (1M) (3M) (12M) Price

More information

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2 21 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $0.37 Share Price $0.31 SNAPSHOT Monthly Turnover $2.5mn Market Cap $91mn Shares Issued 303.9mn 52-Week High $0.43 52-Week

More information

Zip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher

Zip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher Improved medium term cost guidance Z1P s Jun-18 qtrly update outlined a beat against our cash flow expectations, with the company having generated positive operating cash flow (after bad debts) for the

More information

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision. AUSTRALIA TLS AU Price (at 11:23, 21 Jul 2015 GMT) Neutral A$6.43 Valuation A$ 6.37 - DCF (WACC 6.8%, beta 0.8, ERP 5.0%, RFR 3.8%, TGR 1.2%) 12-month target A$ 6.30 12-month TSR % +3.3 Volatility Index

More information

MNF Group Limited (MNF)

MNF Group Limited (MNF) MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market

More information

Vita Group (VTG) COMPANY REPORT. Vitality in question

Vita Group (VTG) COMPANY REPORT. Vitality in question 18 May 2017 INTERNAL ONLY RECOMMENDATIONS Rating HOLD Risk High Price Target $0.85 Share Price $0.90 SNAPSHOT Monthly Turnover $79.4mn Market Cap $137mn Shares Issued 152.6mn 52-Week High $5.47 52-Week

More information

Spotless Group Holdings

Spotless Group Holdings AUSTRALIA SPO AU Price (at 05:45, 31 Jan 2017 GMT) Neutral A$0.94 Valuation - Peer multiples A$ 1.02 12-month target A$ 1.02 12-month TSR % +18.3 Volatility Index High GICS sector Commercial & Professional

More information

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA CCL AU Price (at CLOSE#, 21 Aug 2015) Underperform A$8.78 Valuation A$ 8.47 - DCF (WACC 8.7%, beta 1.0, ERP 5.0%, RFR 3.8%, TGR 1.9%) 12-month target A$ 8.99 12-month TSR % +7.3 Volatility Index

More information

For personal use only

For personal use only APPENDIX 4D / HALF-YEAR REPORT Appendix 4D / Half-Year Report Half-Year Ended 31 December Key Dates 29 February 2012 Announcement of Half-Year Profit to 31 December Announcement of Interim 2012 Dividend

More information

Port of Tauranga. Investor Day update. Investor Day focuses on competitive advantages. Forecast revisions; EPS changes are immaterial (Fig 4)

Port of Tauranga. Investor Day update. Investor Day focuses on competitive advantages. Forecast revisions; EPS changes are immaterial (Fig 4) Australasia New Zealand Emerging Companies Institutional Research Company Update Reuters Bloomberg Exchange Ticker 30 November 2011 Issued by: Craigs Investment Partners Ltd Hold POT.NZ POT NZ NZE POT

More information

PRICE $1.30 Regional Express Holdings Ltd REX

PRICE $1.30 Regional Express Holdings Ltd REX 16 November 2006 PRICE $1.30 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115M Market cap A$133M

More information

Genex Power COMPANY SNAPSHOT. Solar project taking shape

Genex Power COMPANY SNAPSHOT. Solar project taking shape Genex Power COMPANY SNAPSHOT Reuters/Bloomberg: GNX.AX / GNX AU Market cap: US$25.7m A$34.2m Current price: A$0.19 Average daily turnover: US$0.04m A$0.05m Current shares o/s 180.3m Free float: 67.0% Nathan

More information

Sims Metal Management

Sims Metal Management AUSTRALIA SGM AU Price (at 5:11, 17 Nov 215 GMT) Outperform A$7.19 Valuation - EV/EBIT A$ 8.49-9.6 12-month target A$ 8.9 12-month TSR % +26.6 Volatility Index Medium GICS sector Materials Market cap A$m

More information

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision AUSTRALIA QBE AU Price (at 10:44, 27 Apr 2016 GMT) Neutral A$11.19 Valuation A$ - DCF (WACC 9.3%, beta 1.1, ERP 5.0%, RFR 3.8%) 11.34 12-month target A$ 12.00 12-month TSR % +12.7 Volatility Index Low/Medium

More information

Exchange Traded Options. Product Disclosure Statement

Exchange Traded Options. Product Disclosure Statement Exchange Traded Options Product Disclosure Statement Version 3.0 November 2017 Part 1 PDS Information Important Information The information contained in this document is general in nature and is not intended

More information

Resetting expectations

Resetting expectations Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp

More information

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA RHC AU Price (at 06:11, 06 Aug 2015 GMT) Neutral A$66.37 Valuation A$ 64.54 - DCF (WACC 8.1%, beta 1.1, ERP 5.0%, RFR 3.8%, TGR 3.0%) 12-month target A$ 70.00 12-month TSR % +7.3 Volatility Index

More information

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook AUSTRALIA JHC AU Price (at 06:10, 27 Apr 2015 GMT) Outperform A$2.71 Valuation A$ 2.97 - DCF (WACC 9.1%, beta 1.1, ERP 5.0%, RFR 4.5%, TGR 2.3%) 12-month target A$ 3.00 12-month TSR % +14.7 Volatility

More information

Eddie Stobart Logistics

Eddie Stobart Logistics Eddie Stobart Logistics Interims show delivery on growth plans Interim results Industrial support services Eddie Stobart Logistics (ESL) H1 numbers, well trailed at the trading update in July, showed high

More information

APPENDIX 4E YEAR ENDED 30 JUNE 2011

APPENDIX 4E YEAR ENDED 30 JUNE 2011 APPENDIX 4E /PRELIMINARY FINAL REPORT APPENDIX 4E YEAR ENDED 30 JUNE Key Dates 30 August Announcement of Full Year Profit to 30 Announcement of Final Dividend 4 November Record date for determining entitlement

More information

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision. NEW ZEALAND NPX NZ Price (at 05:00, 31 Jul 2015 GMT) Outperform NZ$4.55 Valuation NZ$ 4.40 - DCF (WACC 12.5%, beta 1.4, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 4.75 12-month TSR % +10.6 Volatility

More information

JB Hi-Fi Limited. Full Year Results Presentation 30 June 2009

JB Hi-Fi Limited. Full Year Results Presentation 30 June 2009 JB Hi-Fi Limited Full Year Results Presentation 30 June 2009 11 August 2009 Agenda 1. Performance 2. Historical Performance 3. Trading Update 4. Financial Detail 5. Dividends 6. Store Update 7. Investment

More information

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August AUSTRALIA SRX AU Price (at CLOSE#, 11 Jul 2016) Outperform A$27.88 Valuation A$ 37.93 - DCF (WACC 9.0%, beta 1.2, ERP 5.0%, RFR 3.3%, TGR 1.5%) 12-month target A$ 38.00 12-month TSR % +37.4 Volatility

More information

Cooks Global Foods. Focused on capital requirements results restated. CGF budgets for 650 stores, targets 800 by 2021

Cooks Global Foods. Focused on capital requirements results restated. CGF budgets for 650 stores, targets 800 by 2021 Cooks Global Foods Focused on capital requirements Company update Food & beverages Cooks Global Foods (CGF) has reaffirmed its 650-store budget for Esquires Coffee by March 2021, but has acknowledged that

More information

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA NHF AU Price (at 09:52, 02 Mar 2016 GMT) Outperform A$3.72 Valuation A$ 3.85 - DCF (WACC 8.5%, beta 1.0, ERP 5.0%, RFR 3.8%, TGR 2.5%) 12-month target A$ 4.00 12-month TSR % +11.7 Volatility

More information

Freedom Insurance (FIG)

Freedom Insurance (FIG) 03 November 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Medium Price Target $0.85 Share Price $0.50 SNAPSHOT Monthly Turnover $13.0mn Market Cap $169mn Shares Issued 239.7mn 52-Week High $0.97 52-Week

More information

Tassal Group. Salmon and seafood growth strategy ADD

Tassal Group. Salmon and seafood growth strategy ADD Vol m Food & Beverages Australia Equity research September 14, 2015 ADD Current price: Target price: A$3.82 A$4.20 Previous target: A$ Up/downside: 9.9% Reuters: Bloomberg: Market cap: Average daily turnover:

More information

Up/dow nside 17.8% Figure 1: Financial Summary

Up/dow nside 17.8% Figure 1: Financial Summary Healthcare Equipment and Services AUSTRALIA SomnoMed Limited SOM AU / SOM.AX Analyst Scott POWER T +61 7 3334 4884 E scott.power@morgans.com.au Current A$2.52 Market Cap Avg Daily Turnover Free Float Target

More information

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook AUSTRALIA MRE vs Consensus MQG FY15 Consensus FY15 Date Profit EPS DPS Profit EPS DPS BEN 10-Aug 439 92 67 434 92 67 CBA 12-Aug 9,289 557 420 9,116 554 419 Source: Factset, Macquarie Research, August 2015

More information

Kingsgate Consolidated

Kingsgate Consolidated AUSTRALIA KCN AU Price (at 6:11, 31 Jul 215 GMT) Underperform A$.67 Valuation A$ - DCF (WACC 12.%, beta 1.6, ERP 5.%, RFR 3.8%).3 12-month target A$.3 12-month TSR % -54.9 Volatility Index Very High GICS

More information

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result.

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result. AUSTRALIA ORG AU Price (at 06:11, 30 Jul 2015 GMT) Neutral A$11.35 Valuation A$ 12.79 - DCF (WACC 10.3%, beta 1.3, ERP 5.0%, RFR 3.8%, TGR 2.0%) 12-month target A$ 12.89 12-month TSR % +18.1 Volatility

More information

Asset revaluation driven by almonds

Asset revaluation driven by almonds Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of

More information

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SFR AU Price (at 6:11, 7 Jul 216 GMT) Outperform A$5.34 Valuation A$ - DCF (WACC 9.%, beta 1.4, ERP 5.%, RFR 3.3%) 5.82 12-month target A$ 6.1 12-month TSR % +18.3 Volatility Index Medium GICS

More information

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation 1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57

More information

Fisher & Paykel Healthcare

Fisher & Paykel Healthcare NEW ZEALAND FPH NZ Price (at 03:59, 16 Mar 2015 GMT) Outperform NZ$6.63 Valuation NZ$ 6.86 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.25 12-month TSR % +11.6 Volatility

More information

APPENDIX 4E YEAR ENDED 30 JUNE 2010

APPENDIX 4E YEAR ENDED 30 JUNE 2010 APPENDIX 4E PRELIMINARY FINAL REPORT APPENDIX 4E YEAR ENDED 30 JUNE Key Dates 27 August Announcement of Profit for Year Ended 30 Announcement of Final Dividend 5 November Record date for determining entitlement

More information

Trevi Group Italy Capital goods

Trevi Group Italy Capital goods 30 August 2013 Trevi Group Italy Capital goods Buy (Hold) Target price EUR6.90 Current price EUR6.22 Matteo Bonizzoni, CFA mbonizzoni@keplercheuvreux.com +39 02 80 62 83 43 Sound delivery and business

More information

RESULTS FOR HALF-YEAR ENDED 31 DECEMBER 2010: PROFIT BEFORE TAX FROM CONTINUING OPERATIONS $198.61M vs $237.77M DOWN 16.5%

RESULTS FOR HALF-YEAR ENDED 31 DECEMBER 2010: PROFIT BEFORE TAX FROM CONTINUING OPERATIONS $198.61M vs $237.77M DOWN 16.5% Harvey Norman Holdings Limited 1 ACN 003 237 545 25 February 2011 RESULTS FOR HALF-YEAR ENDED 31 DECEMBER : PROFIT BEFORE TAX FROM CONTINUING OPERATIONS $198.61M vs $237.77M DOWN 16.5% Harvey Norman Holdings

More information

Half Year Results Presentation December February 2008

Half Year Results Presentation December February 2008 JB Hi-Fi Limited Half Year Results Presentation December 2007 12 February 2008 AGENDA 1. Performance 2. Historical Performance 3. Trading Update 4. Financial Detail 5. Dividends 6. Store Update 7. Investment

More information

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SEK AU Price (at 06:33, 07 Apr 2017 GMT) Outperform A$16.33 Valuation - Sum of Parts A$ 16.77 12-month target A$ 16.50 12-month TSR % +3.9 Volatility Index Low/Medium GICS sector Commercial &

More information

Fisher & Paykel Healthcare

Fisher & Paykel Healthcare NEW ZEALAND FPH NZ Price (at 05:00, 10 Jul 2015 GMT) Outperform NZ$7.03 Valuation NZ$ 7.39 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.80 12-month TSR % +13.1 Volatility

More information

Regional Express Holdings Ltd REX

Regional Express Holdings Ltd REX 20 February 2006 REX $1.15 Analyst Ken Fleming (613) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (613) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$132.3M Performance & Valuation Last

More information

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SIV AU Price (at 08:50, 21 Mar 2017 GMT) Neutral A$7.71 Valuation - PER A$ 6.68 12-month target A$ 6.68 12-month TSR % -7.4 Volatility Index Medium GICS sector Capital Goods Market cap A$m 278

More information

Healthcare - Overall. Patient in the ER but remains alive and well. Sector Note. Overweight (no change)

Healthcare - Overall. Patient in the ER but remains alive and well. Sector Note. Overweight (no change) Sector Note Overweight (no change) Highlighted companies CSL ADD, TP A$103.75, A$105.35 close A well-diversified product portfolio and reinvesting for future growth as the R&D pipeline evolves, with ongoing

More information

Tatts Group. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Underperform on valuation grounds.

Tatts Group. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Underperform on valuation grounds. AUSTRALIA TTS AU Price (at 8:37, 23 Aug 212 GMT) Underperform A$2.79 Volatility index Low 12-month target A$ 2.45 12-month TSR % -6.8 Valuation - Sum of Parts A$ 2.4-2.47 GICS sector Consumer Services

More information

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision. AUSTRALIA ECX AU Price (at 02:49, 15 Dec 2016 GMT) Outperform A$3.77 Valuation - PER A$ 3.53-3.78 12-month target A$ 4.22 12-month TSR % +16.3 Volatility Index Low/Medium GICS sector Diversified Financials

More information

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected B a sl er A G # $T ypcap$ 1576 14 1 1 x 6495 2 Page 1/6 First Take Reco. lowered Neutral vs Buy Electronics Germany Neutral Target price : 60.00 EUR vs 52.00 EUR Price (11/01/2016) : 58.04 EUR Upside :

More information

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views AUSTRALIA 4 February 2016 Macquarie Securities (Australia) Limited Aust. Fund managers review & rank Event We review and rank the listed Australian under Macquarie Securities coverage, assessing fund performance,

More information

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts Date 09 January 2018 Theme Company Update Company Noni B (NBL) BUY: FY18e EBITDA +12.8% NBL provided a positive 1H18 trading update today, advising LFL sales growth of 3.0% (1.5% in 1H17) and EBITDA of

More information

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA OZL AU Price (at 08:20, 22 Jul 2016 GMT) Underperform A$6.51 Valuation A$ - DCF (WACC 9.0%, beta 1.4, ERP 5.0%, RFR 3.3%) 4.31 12-month target A$ 5.00 12-month TSR % -21.4 Volatility Index High

More information

Fairfax / REA Group. No housing boom here. A$0.81 Valuation A$ Sum of Parts 12-month target A$ month TSR % +16.0

Fairfax / REA Group. No housing boom here. A$0.81 Valuation A$ Sum of Parts 12-month target A$ month TSR % +16.0 AUSTRALIA FXJ AU Price (at 05:11, 03 Nov 2016 GMT) Outperform A$0.81 Valuation A$ 0.88 - Sum of Parts 12-month target A$ 0.90 12-month TSR % +16.0 Volatility Index Low/Medium Market cap A$m 1,863 30-day

More information

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA RRL AU Price (at 7:29, 13 2 GMT) Outperform A$1.29 Valuation A$ - DCF (WACC 9.%, beta 1.5, ERP 5.%, RFR 3.8%) 1.68 12-month target A$ 1.7 12-month TSR % +37.2 Volatility Index High GICS sector

More information

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA OSH AU Price (at 05:10, 16 Feb 2017 GMT) Outperform A$7.11 Valuation A$ - DCF (WACC 8.5%, beta 1.4, ERP 5.0%, RFR 3.3%) 6.70 12-month target A$ 7.60 12-month TSR % +8.2 Volatility Index Medium

More information

Byron Energy Net Reserves (at 30 June, 2014)

Byron Energy Net Reserves (at 30 June, 2014) Energy AUSTRALIA Byron Energy Ltd BYE AU / BYE.AX Market Cap Avg Daily Turnover Free Float A$100m US$0.1m 66.0% US$87.5m A$0.1m 95.20m shares Krista WALTER T +61 7 3334 4775 E krista.walter@morgans.com.au

More information

Vista Group International

Vista Group International NEW ZEALAND VGL NZ Price (at 03:15, 26 Feb 2015 GMT) Outperform NZ$4.35 Valuation NZ$ 4.31 - DCF (WACC 9.9%, beta 1.0, ERP 7.0%, RFR 4.0%, TGR 2.0%) 12-month target NZ$ 4.75 12-month TSR % +9.5 Volatility

More information

Genworth Mortgage Insurance Australia

Genworth Mortgage Insurance Australia AUSTRALIA GMA AU Price (at 07:29, 05 Aug 2015 GMT) Outperform A$3.50 Valuation A$ - DCF (WACC 12.0%, beta 1.6, ERP 5.0%, RFR 4.5%) 3.52 12-month target A$ 3.47 12-month TSR % +9.2 Volatility Index Medium

More information

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA AU Price (at 08:17, 03 Sep 2012 GMT) Underperform A$10.52 Volatility index Low 12-month target A$ 11.08 12-month TSR % +12.0 Valuation A$ - DCF (beta 1.1, ERP 5.0%, RFR 6.0%, TGR 2.5%) 15.09

More information

Shareholders Benefits

Shareholders Benefits Special Bulletin Shareholders Benefits 7 October 2009 Companies Ardent Leisure Amalgamated Holdings Australian Agricultural Company AMP Limited Bank of Queensland Bendigo & Adelaide Bank Blackmores Tabcorp

More information

Bendigo and Adelaide Bank

Bendigo and Adelaide Bank AUSTRALIA AU Price (at 06:17, 30 Mar 2017 GMT) Underperform A$12.03 Valuation A$ 11.48- - Sum of Parts/GG 11.71 12-month target A$ 11.50 12-month TSR % +1.2 Volatility Index Low/Medium GICS sector Banks

More information

UBS Investment Research Brambles Limited

UBS Investment Research Brambles Limited UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying

More information

Gear4music Holdings. Market share gains and margin boost. Strong pre-christmas trading. FY18 forecast maintained

Gear4music Holdings. Market share gains and margin boost. Strong pre-christmas trading. FY18 forecast maintained Gear4music Holdings Market share gains and margin boost January trading statement Retail Gear4music s (G4M) Christmas trading statement shows it continuing to take share in its niche markets to generate

More information

Generation Healthcare REIT

Generation Healthcare REIT AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap

More information

Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA KAR AU Price (at 05:10, 16 Mar 2017 GMT) Outperform A$1.63 Valuation A$ - DCF (WACC 11.1%, beta 1.7, ERP 5.0%, RFR 3.3%) 2.79 12-month target A$ 2.40 12-month TSR % +47.7 Volatility Index High

More information

Byron Energy Ltd. Riding the waves at Byron ADD

Byron Energy Ltd. Riding the waves at Byron ADD Vol th Oil & Gas Exp & Prodn Australia Equity research November 30, 2015 ADD Current price: Target price: A$0.19 A$0.59 Previous target: A$ Up/downside: 208.4% Reuters: Bloomberg: Market cap: Average daily

More information

Pinnacle Investment Management

Pinnacle Investment Management The pinnacle of execution Pinnacle provided a FUM update and 1H18 guidance which were both well ahead of our expectation, driven by rapid retail and insto inflows. FUM at Dec-17 of $32.4b sits above our

More information

PRICE $1.16 Regional Express Holdings Ltd REX

PRICE $1.16 Regional Express Holdings Ltd REX 13 September 2006 PRICE $1.16 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$121.9M

More information

SeaLink Travel Group (SLK)

SeaLink Travel Group (SLK) 29 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Medium Price Target $5.10 Share Price $4.45 SNAPSHOT Monthly Turnover $9.3mn Market Cap $446mn Shares Issued 101.2mn 52-Week High $4.46 52-Week

More information

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA TOX AU Price (at 05:10, 30 Nov 2016 GMT) Outperform A$2.34 Valuation - EV/EBITDA A$ 2.52-3.07 12-month target A$ 2.79 12-month TSR % +23.1 Volatility Index Medium GICS sector Commercial & Professional

More information

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation AUSTRALIA CIM AU Price (at 05:10, 31 Mar 2017 GMT) Outperform A$35.93 Valuation A$ 42.69 - DCF (WACC 8.5%, beta 1.4, ERP 5.0%, RFR 3.3%, TGR 2.0%) 12-month target A$ 42.50 12-month TSR % +22.0 Volatility

More information